title: Nuclear lesions during rat hepatocarcinogenesis. II. Measuring the micronuclei during initiation, promotion and progression of rat hepatocarcinogenesis induced with diethylnitrosamine.
abstract: We reported in our companion paper the strong correlation between elevated sister-chromatid exchange (SCE) frequencies and the initiation step of rat hepatocarcinogenesis. We have also shown that SCEs return to normal values during the promotion and the progression stages. In the present study, we evaluated the clastogenic activity of diethylnitrosamine (DEN) during initiation, promotion and progression of rat hepatocarcinogenesis. We measured, at various times after DEN administration, the number of micronuclei (MN) produced by the mitotic response to partial hepatectomy. The results established that the DEN treatment induces a great number of preclastogenic lesions. In subcarcinogenic conditions (initiation alone), the number of MN expressed after partial hepatectomy remains high regardless of the time interval between the end of the DEN treatment and the operation. In this condition, the preclastogenic lesions persist for up to 1 year after the DEN administration is discontinued. Conversely, in carcinogenic conditions (initiation + promotion + progression), the number of MN expressed after partial hepatectomy decreases during the promotion and progression stages. These observations indicate that promotion and progression but not initiation are associated with the expression of persistent preclastogenic lesions, resulting in the production of chromosomally abnormal hepatocytes.
authors.affiliation: Department of Genetics, University of Liège, CHU, Belgium.
authors.forename: C
authors.initials: C
authors.lastname: Herens
authors.forename: S
authors.initials: S
authors.lastname: Massart
authors.forename: B
authors.initials: B
authors.lastname: Bouzahzah
authors.forename: L
authors.initials: L
authors.lastname: Koulischer
authors.forename: H
authors.initials: H
authors.lastname: Barbason
mesh_terms: D000818:Animals; D002471:Cell Transformation, Neoplastic; D002869:Chromosome Aberrations; D004052:Diethylnitrosamine / Q000494:pharmacology*; D006498:Hepatectomy; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D008297:Male; D015162:Micronucleus Tests; D008940:Mitotic Index / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar
chemical_list: D004052:Diethylnitrosamine